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Abstract 
Copper was bound to modified peptides that selectively target the 16S ribosomal RNA of 
Escherichia Coli (E. Coli) and contain an amino terminal copper and nickel binding motif; and 
subsequent RNA cleavage studied.  The metallopeptides (shown in Figure 1) Cu-
GGHHPVHHYQ, Cu-GGHGHPVHHYQ, Cu-GGHGGHPVHHYQ, Cu-GGHGWRWYCR, and 
Cu-GGHGLPLTPLP were able to effectively transport the reactive metal center to the Fl-16S-
rRNA to perform cleavage reactions.  Initial cleavage rates were analyzed by polyacrilamide gel 
electrophoresis (PAGE) and found to be up to 120 nM/min with coreagents H2O2 and ascorbate, 
up to 2 nM/min with ascorbate, and up to 2.4 nM/min with no reagents.  Matrix assisted laser 
desorption/ionization- time of flight mass spectrometry (MALDI-TOF MS)  was used to detect 
RNA cleavage fragments with 6 easily identifiable nascent overhangs; 3’-hydroxyl , 2’,3’-cyclic 
phosphate, 3’-phosphate, 3’-phosphoglycolate, 5’-hydroxyl, and 5’-phosphate at specific sites 
along the RNA sequence.  Apparent initial rates of reaction were also determined from MALDI-
TOF MS that were generally agreeable with initial rates determined by PAGE.  The program 
MassDaddy (Jeff Joyner) was used to analyze mass spectra by comparing observed mass peaks 
to expected mass lists for cleavage products within a mass matching error of 200 ppm.  This 
series of metallopeptides, with special focus on the hydrolytic cleavage shown by 
GGHGWRWYCR, shows promise in being able to target the 16S ribosomal RNA of E. Coli and 
function as an antibacterial drug.   
 
 
 
 
Introduction  
Antibacterial drugs are a major topic of study due to the slowly growing populations of 
antibiotic-resistant bacteria.  Antibiotics have been in use for over 60 years, and it is becoming 
more common for antibiotic-resistant bacteria to infect humans.  For example, shiga toxin-
producing E. Coli can cause haemorrhagic colitis and haemolytic uraemic syndrome in the 
intestine and cannot be treated with most antibiotics [1].  Constant use of antibiotics by humans 
both as a medical treatment as well as a drug in other industries (such as farm animal industry) 
has enabled a population growth of antibiotic-resistant bacteria in the environment [2].  New 
methods of treatment must be developed in order to combat this threat.   
The 16S ribosomal RNA of E. Coli is responsible for translation of proteins that are key 
to the bacteria’s function and is often targeted in order to treat bacterial infections.  Common 
antibiotics such as paromomycin and neomycin B bind to the 16S ribosomal RNA and interfere 
with translation which ultimately leads to the death of the bacteria [3].  There are many ways that 
antibiotic-resistant bacteria have developed immunities to these aminoglycoside antibiotics.  
Simple base pair mutations in the structure of the 16S-rRNA can inhibit antibiotics from being 
able to bind due to structural changes [3].  Efflux pumps are proteins in bacteria that can rapidly 
pump antibiotics out of the cell [4].  Other antibiotic-resistant bacteria are able to enzymatically 
deactivate antibiotics or are impermeable to certain antibiotics [5; 6].  Novel drugs that are able 
to bypass these defensive mechanisms and target the 16S-rRNA are of great importance in order 
to treat infections that are caused by antibiotic-resistant bacteria. 
Using specific peptides to target the 16SrRNA of E. coli is a possible answer to 
overcoming bacterial defense mechanisms.  The peptide HPVHHYQ has been shown to bind to 
16S ribosomal RNA with a moderate binding affinity (KD = 16 μM) and the peptide LPLTPLP 
has also been shown to have selectivity for 16S-rRNA via an on-bead fluorescence assay [7].  
The peptide WRWYCR has also been shown to have antimicrobial activity by affecting several 
iron regulatory proteins; such that iron levels reach a high level of toxicity in the bacteria and the 
ferric uptake regulatory protein is unable to bind free iron [8].  WRWYCR is also able to inhibit 
formation of a Holliday junction in bacteria compromising the ability for genetic recombination 
[8].  The shiga toxin-producing E. Coli mentioned above has also been shown to be effectively 
treated by peptide WRWYCR [1].   
Artificial nuclease derivatives of these peptides were synthesized and cleavage of 
fluorescein labeled 16S ribosomal RNA was studied.  These copper bound peptides are part of a 
family of metal chelates previously studied by the Cowan lab which are shown to bind and 
transport reactive metal centers to active sites of nucleic acids [9; 10].  RNA cleavage reactions 
were carried out using both copper bound peptides, non copper bound GGHGWRWYCR, and 
free Cu under oxidative and non-oxidative conditions.  Rates of reaction were determined 
through the analysis of time dependent reactions by use of PAGE and MALDI-TOF mass 
spectrometry.  
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Figure 1. Summary of copper peptide complexes studied.  The binding of copper (M) is shown 
at the GGH terminal end of the peptides.  (A) Cu-GGHHPVHHYQ, (B) Cu-GGHGHPVHHYQ, 
(C) Cu-GGHGGHPVHHYQ,  (D) Cu-GGHGWRWYCR, (E) Cu-GGHGLPLTPLP, (F) Cu-
GGH 
Materials 
Fluorescein labeled 16S-rRNA with sequence Fl-GGCGUCACACCUUCGGGUGAAG-
UCGCC was purchased from Dharmacon.  Peptides GGHHPVHHYQ, GGHGHPVHHYQ, 
GGHGGHPVHHYQ, GGHGWRWYCR, and GGHGLPLTPLP were purchased from Genemed 
Synthesis Inc, while peptide GGH was purchased from Bachem.  Both RNA and peptides were 
immediately aliquoted into single use containers and stored at -20⁰ C to minimize freezing and 
thawing the reagents.  Sodium chloride, hydrogen peroxide, and sodium hydroxide were 
purchased from Fisher, and HEPES was purchased from Sigma.  Ascorbate was purchased from 
Fluka.  Ni(II) tetrahydrate and Cu(II) chloride were purchased from Aldrich and J.T. Baker 
respectively.  C18 zip-tips and acetonitrile were obtained from Millipore and Fisher, respectively.  
Matrix components ammonium citrate and 3-hydroxypicolinic acid were obtained from Aldrich 
and Sigma-Aldrich, respectively. 
 
Methods 
 
Characterization 
Peptides were assumed to have purity provided on the manufacturer’s label and were 
dissolved in H2O to an estimated concentration of 10 mM.  Titrations were then performed using 
500 μL of estimated 100 μM peptides, titrating with 1 mM Ni(II) tetrahydrate.  UV/Vis 
spectroscopy was used to detect absorbance peaks correlating to Ni-GGH at 245 nm and 430 nm.  
The end point of the titration was then determined in order to calculate the concentrations of the 
peptides.  Peptides were bound to copper at a 1.5:1 ratio and allotted a time period of 30 min to 
allow complete binding of the copper. 
Polyacrilamide Gel Electrophoresis (PAGE) 
Time dependent RNA cleavage reactions were performed with 10 μM Fl-16S-rRNA, 10 
μM Cu:Peptide, 1 mM H2O2, and 1 mM ascorbate in separate tubes, each containing 20 μL of 
total volume, at 37⁰ C.  A 20 mM HEPES and 100 mM NaCl buffer at pH 7.4 was used for all 
reactions.  The Fl-16S-rRNA was heated to 90⁰ C for 5 min and allowed to refold at 37⁰ C before 
the reactions were started.  Reaction tubes were incubated together with Fl-16S-rRNA in a dark 
incubator and reaction starting times were staggered.  Reactions were incubated up to 8 hours 
and 2 μL of the product mixture was quenched with 998 μL of a 1× Tris-EDTA-acetic acid 
buffer, 8 M urea, 20 mM HEPES, and 100 mM NaCl, then heated to 90⁰ C again.  The remaining 
18 μL of the product mixture were placed onto ice for MALDI-TOF MS analysis.  Then 5 μL 
from each quenched reaction tube were loaded into a 10% polyacrilamide 8 M urea gel, such that 
each gel lane contained 0.1 pmol of Fl-RNA; electrophoresis was performed at 250 V for 1 hour.  
RNA bands were visualized by using a GE Typhoon variable mode imager by exciting the 5’-
fluorescein-labeled RNA at 488 nm with a single-pass emission filter at 526 nm.  Gel bands were 
quantified by using the program ImageQuant.  Time dependent disappearance of initial Fl-16S-
rRNA was fit to a first-order reaction equation using the program Origin, and initial rates and 
rate constants were determined from the data.  Reactions were also carried with only 1 mM 
ascorbate as a coreactant, as well as no coreactants. 
  
MALDI-TOF MS (Matrix assisted laser desorption/ionization-time of flight mass 
spectrometry) 
 Reactions were performed as described above and quenched by immediately placing on 
ice, followed by desalting and collection of the the Fl-RNA products from the remaining 18 μL 
of product mixture, which was set aside for MALDI-TOF MS analysis, by zip-tipping with a C18 
column.  The column was first washed 2 times with 10 μL 50% (by volume) acetonitrile and 
50% (by volume) H2O, then 3 times with 10 μL 2 M triethylamine acetate.  The Fl-RNA 
products were then extracted from the reaction tubes by loading onto zip-tips, washed 3 times 
with 10 μL 2 M triethylamine acetate, 3 times with 10 μL H2O, and then subsequently eluted into 
5 μL 50% (by volume) acetonitrile and 50% (by volume) H2O at 0⁰ C.  
 
MALDI-TOF MS Analysis 
 Eluted Fl-16S-rRNA products were then mixed with 2.5 μL of a matrix solution 
containing 42 mg/mL 3-hydroxy picolinic acid and 6.8 mg/mL ammonium citrate in 30% (by 
volume) acetonitrile and 70% (by volume) water.  A Bruker ground steel 96 target microScout 
plate was pre-spotted with 1 μL of the matrix mixture and allowed to dry.  Then 2.5 μL of the 
RNA/matrix mixture was spotted on pre-spotted targets and allowed to dry.  Three separate RNA 
calibration mixtures of Fl-5mer, Fl-IRESSLIV, and Fl-RRE, with molecular weights of 2057.5, 
8851.5, and 12172.5 amu, respectively, were spotted onto the plate under these same conditions.  
These mixtures were used to calibrate the MALDI-TOF mass spectrometer prior to analysis of 
reaction products.  Analysis was performed on a Bruker MicroFlex LRF instrument.  Mass 
spectra obtained were smoothed and peaks were detected by using the Bruker flexAnalysis 
program.  Observed peaks were compared to an expected mass list by the program MassDaddy 
(Jeff Joyner) and mass peaks were identified within an error of 200 ppm.  Peaks that were under 
1000 amu were not assigned due to an exceedingly large amount of possible cleavage products 
that could be present.  Other unassigned peaks may have been catalysts or artifactual products 
that were formed during MALDI-TOF MS analysis. 
Results 
 
Characterization 
 The solutions of estimated 10 mM peptides were determined to not be as pure as 
estimated (by weight) and have actual lower concentrations.  The peptide GGHGHPVHHYQ 
was determined to have a correction factor of 48.1% such that the original solution was 4.81 mM 
(rather than 10 mM).  The original solution of the peptide GGHGGHPVHHYQ was determined 
to be 4.94 mM, and similar concentrations were also determined for the remaining peptides. 
 
PAGE Analysis of RNA Cleavage 
Copper bound peptides were incubated with Fl-16S-rRNA,with either 1 mM H2O2 and 1 
mM ascorbate, 1 mM ascorbate, or no coreactants.  Control experiments were also performed 
that lacked catalyst, with either 1 mM H2O2 and 1 mM ascorbate, or no coreactants.  Reactions 
were also performed with unbound peptide GGHGWRWYCR in order to compare rates of 
copper and metal free GGHGWRWYCR.  The reactivity of free copper and Cu-GGH was also 
tested and showed high rates of cleavage of RNA, but only when 1 mM H2O2 and 1 mM 
ascorbate were both present.  The rate for each complex was determined by the rate of 
disappearance of the band of full length RNA visualized by gel electrophoresis.  Initial rates of 
reactions for these complexes are summarized in Tables 1, 2, and 3.  The metallopeptides Cu-
GGHGWRWYCR, Cu-GGHGHPVHHYQ, and Cu-GGH showed the highest initial rates of 
RNA cleavage among the copper peptide complexes for reactions with 1 mM H2O2/ascorbate 
and 1 mM ascorbate.  Free copper also showed a high initial rate of RNA cleavage.  Rates of 
reaction with 1 mM H2O2/ascorbate were significantly faster than rates of reaction with 1 mM 
ascorbate, indicating that either the complexes are more reactive under more oxidative 
conditions, the RNA is less stable under more oxidative conditions, or both.  In general 
hydrolytic reactions showed no cleavage of RNA, except for copper bound and metal free 
peptide GGHGWRWYCR, which elicited relatively rapid formation of a product band by PAGE 
analysis. 
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Figure 2. Time dependent cleavage of Fl-16S-rRNA by Cu-GGHGWRWYCR with coreactants 
hydrogen peroxide and ascorbate. (Top) Disappearance of full-length RNA monitored by PAGE, 
(Bottom) Gel image showing disappearance of full-length RNA between RNA ladders. 
 
 
 
 
MALDI-TOF MS Analysis of RNA Cleavage 
Copper-bound peptides were incubated with Fl-16S-rRNA, with either 1 mM H2O2 and 1 
mM ascorbate or no coreactants.  Control experiments were also performed under all of these 
conditions.  RNA product mixtures were desalted using C18 zip-tips and analyzed by MALDI-
TOF MS.  Products resulting from single-cleavage events were analyzed using the program 
MassDaddy, which compares observed MS peaks to an expected mass list, containing expected 
masses for RNA cleavage products.  The automation was necessary due to the large amount of 
data that need to be organized for every time point of every RNA cleavage reaction.  The RNA 
cleavage products that were studied were fragments containing one of 6 easily identifiable 
nascent overhangs; 3’-hydroxyl , 2’,3’-cyclic phosphate, 3’-phosphate, 3’-phosphoglycolate, 5’-
hydroxyl, and 5’-phosphate.  It was necessary for the expected mass list to contain unique 
masses for RNA fragments corresponding to all possible RNA modifications at every position 
along the 16S-rRNA sequence.  In this way it was also made possible to approximate cleavage 
rates along the RNA sequence by using mass spectrometry.  Identified peaks can be seen in 
Figures 3, 4, 5, and 6.  By monitoring the increasing peak area fractions of these products over 
time it was possible to identify that products were formed due to Cu-peptide cleavage and not 
formed due to artifactual cleavage caused by MALDI-TOF MS.  Relative rates of formation of 
separate cleavage products, as well as disappearance of full-length RNA, were measured over 
time and used to determine apparent initial rates of RNA cleavage (Tables 1, 2, and 3), as 
discussed later. 
 
 
 
 
Figure 3. Mass Spectrum of RNA cleavage by Cu-GGHGWRWYCR with 1 mM H2O2 and 1 
mM ascorbate at 120 min.  
 
 
 
 
Figure 4. Zoomed Mass Spectrum of RNA cleavage by Cu-GGHGWRWYCR with 1 mM H2O2 
and 1 mM ascorbate at 120 min. 
 
 
 
 
 
Figure 5. Mass Spectrum of RNA cleavage by GGHGWRWYCR with no coreactants at 6 hr.  
 
 
Figure 6. Zoomed Mass Spectrum of RNA cleavage by GGHGWRWYCR with no coreactants 
at 6 hr. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Initial rates of cleavage of 10 μM Fl-16S-rRNA by 10 μM Cu-peptides with 1 mM 
H2O2 and 1 mM ascorbate. 
Complex PAGE Analysis MALDI-TOF MS Analysis 
  Fl-RNA cleavage  (nM/min) apparent Fl-RNA cleavage rate (nM/min) 
Cu-GGHGHPVHHYQ 120 ± 20 45 
Cu-GGHGGHPVHHYQ 30 ± 20 63 
Cu-GGHGLPLTPLP < 10 0.1 
Cu-GGHGWRWYCR 100 ± 30 97 
Cu-GGHHPVHHYQ 1 ± 7 13 
Cu-GGH 150 ± 20 160 
Free Cu(II) 900 ± 100 530 
no complex 5 ± 8 10 
 
Table 2. Initial rates of cleavage of 10 μM Fl-16S-rRNA by 10 μM Cu-peptides with 1 mM 
ascorbate. 
Complex PAGE Analysis MALDI-TOF MS Analysis 
  Fl-RNA cleavage  (nM/min) apparent Fl-RNA cleavage rate (nM/min) 
Cu-GGHGHPVHHYQ 2 ± 10 n.d. 
Cu-GGHGGHPVHHYQ 0 ± 7 n.d. 
Cu-GGHGLPLTPLP 0 ± 10 n.d. 
Cu-GGHGWRWYCR 1.4 ± 0.2 n.d. 
Cu-GGHHPVHHYQ 0 ± 6 n.d. 
Cu-GGH 70 ± 10 n.d. 
Free Cu(II) n.d. n.d. 
no complex n.d. n.d. 
 
Table 3. Initial rates of cleavage of 10 μM Fl-16S-rRNA by 10 μM Cu-peptides with no 
coreactants. 
Complex PAGE Analysis MALDI-TOF MS Analysis 
  Fl-RNA cleavage  (nM/min) apparent Fl-RNA cleavage rate (nM/min) 
Cu-GGHGHPVHHYQ 0.00 ± 0.07 10.7 
Cu-GGHGGHPVHHYQ 0.3 ± 0.2 8.8 
Cu-GGHGLPLTPLP 0.07 ± 0.07 9.5 
GGHGWRWYCR 2.4 ± 0.5 14.4 
Cu-GGHGWRWYCR 2 ± 2 33.1 
Cu-GGHHPVHHYQ 0.1 ± 0.1 8.9 
Cu-GGH 0.2 ± 0.5 10.1 
Free Cu(II) 0.2 ± 0.7 10.7 
no complex 0 ± 0.1 12 
 
*n.d.: These rates have not been determined. 
Discussion 
 
Characterization of Peptides 
 It was very important to determine the exact concentration of the peptides in order to 
ensure that there was enough peptide in the Cu-peptide complex mixtures.  If there was not 
enough peptide to bind all of the copper, then cleavage of the RNA would not have only been the 
result of the metallopeptide, but also that of free copper which would have complicated the 
cleavage data. 
 
PAGE Analysis of RNA Cleavage Kinetics 
Reactions containing the oxidative coreagents, 1 mM H2O2 and 1 mM ascorbate, 
generally showed higher initial rates of RNA cleavage, while most metallopeptides were 
unreactive under hydrolytic conditions with no coreactants.  However, a notable exception was 
observed for Cu-GGHGWRWYCR and GGHGWRWYCR, and will be discussed later. 
The Cu-peptide complexes Cu-GGHGHPVHHYQ and Cu-GGHGWRWYCR showed 
the highest initial rates of RNA cleavage among the Cu-peptide complexes, with their initial 
rates with 1 mM H2O2 and 1 mM ascorbate being 120 nM/min and 100 nM/min respectively.  
The peptide GGHGHPVHHYQ is part of the family of peptides in this study that contains the 
HPVHHYQ peptide known to target 16S-rRNA.  This specific peptide most likely has a higher 
initial rate of cleavage than the other HPVHHYQ-derived peptides due to the single glycine 
linker connecting the peptide to the terminal copper binding GGH sequence.  This single linker 
most likely allows the catalyst to attain a more favorable structure and/or alignment with respect 
to the Fl-16SrRNA promoting faster cleavage under oxidative conditions.    
Cu-GGH and free copper also had high initial rates of RNA cleavage, this could be due to 
a copper binding site on the 16SrRNA, allowing these complexes to bind tightly to the RNA and 
effect cleavage.  Also, these catalysts may be more reactive with the coreactants, causing a 
greater production of reactive oxygen species that cause cleavage of the RNA [8].   
 
MALDI-TOF MS Analysis of RNA Cleavage Kinetics 
 The peak area fractions for each species at each time point were used in order to 
determine apparent initial rates for each complex studied.  All observed peak areas output by 
MassDaddy for one time point were summed together, and each individual peak area was 
divided by this sum in order to obtain peak area fractions.  Apparent mole fractions were then 
estimated from these peak area fractions and used to calculate the apparent initial rates of 
cleavage.  This method has limitations because it does not take into account all the peaks in any 
mass spectrum that are products from the RNA.  There is also a bias on the size of the molecules 
detected, since larger molecules are not as readily detected as smaller ones by mass spectrometry 
[11].  Also peaks that were below an m/z of 1000 were not analyzed because of the complication 
of identifying RNA products resulting from multiple cleavage events. 
 
Comparison of PAGE to MALDI-TOF MS 
 With the limitations previously stated that MALDI-TOF MS present when attempting to 
determine initial rates of RNA cleavage it is not surprising to find that rates between PAGE and 
MALDI-TOF analysis do not completely agree.  With this being said, however, many of the 
MALDI-TOF initial rates do strongly support the PAGE analysis, as can be seen with the initial 
RNA cleavage by Cu-GGHGWRWYCR and Cu-GGH with 1 mM H2O2 and 1 mM ascorbate 
(Table 1).  In general, MALDI-TOF MS apparent initial rates of RNA cleavage are able to 
support PAGE data to a certain extent, since the determined rates are within the same magnitude. 
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Figure 7.  Plotted initial rates of RNA cleavage determined by MALDI-TOF MS vs. PAGE for 
each catalyst with 1 mM H2O2 and 1 mM ascorbate.  
 
 
Activity of WRWYCR 
 Previous studies have shown that peptide WRWYCR is an antimicrobial agent through a 
handful of proposed mechanisms [8].  WRWYCR interferes with the correct function of the 
ferric uptake regulatory protein and also inhibits genetic recombination in bacteria by interfering 
with the regular processing of Holliday junctions [8, 12].  Our study shows that these may not be 
the only mechanisms of antimicrobial activity for peptide WRWYCR.  Under hydrolytic 
conditions the peptide GGHGWRWYCR and metallopeptide Cu-GGHGWRWYCR were able to 
cleave Fl-16S-rRNA.  Only these catalysts showed product formation by PAGE analysis.  
MALDI-TOF MS analysis of Cu-GGHGWRWYCR and GGHGWRWYCR showed formation 
of 2, 3’-cyclic phosphate at position 5 along the RNA (Figure 8 and 9), indicating that these 
catalysts promote nucleophilic attack by the 2’-O to nearby phosphate group [13].  Other 
catalysts showed no major products as can be seen in Figure 10.  Cleavage by metallopeptides 
with coreactants 1 mM H2O2 and 1 mM ascorbate showed a wider distribution of product 
formation, showing 2’, 3’-cyclic phosphate, 3’-phosphate, and 3’-phosphoglycolate as major 
products (Figure 11).  This study proposes that the antimicrobial activity of peptide WRWYCR 
may be due not only to its inhibition of iron regulation and Holliday junctions, but also due to its 
ability to cleave the 16S ribosomal RNA of E. coli.  The ability for these catalysts to cleave the 
Fl-16S-rRNA is interesting, since it shows that the catalysts have unique activity that degrades 
the RNA.  This likely makes WRWYCR an ideal candidate for antibacterial use, since it displays 
several mechanisms by which it could possibly have antimicrobial activity.  Antibiotic-resistant 
bacteria would have to be resistant to all of the antimicrobial activity of WRWYCR in order to 
survive treatment. 
 
 
 
 Figure 8. Apparent initial rates of formation of several cleavage products from reaction of Fl-
16S-rRNA with Cu-GGHGWRWYCR and no coreactants. 
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Figure 9. Apparent initial rates of formation of several cleavage products from reaction of Fl-
16S-rRNA with GGHGWRWYCR and no coreactants. 
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 Figure 10. Apparent initial rates of formation of several cleavage products from reaction of Fl-
16S-rRNA with every catalyst and no coreactants. 
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 Figure 11. Apparent initial rates of formation of several cleavage products from reaction of Fl-
16S-rRNA with every catalyst, 1 mM H2O2, and 1 mM ascorbate. 
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Conclusions 
This study shows effective cleavage of the Fl-16S-rRNA by several Cu-peptide 
complexes and the products formed.  Metallopeptides based off of the HPVHHYQ peptide 
showed effective cleavage of the Fl-16S-rRNA.  Cu-GGHGHPVHHYQ showed the highest rates 
of cleavage, possibly due to its single glycine linker lending it a more favorable structure to bind 
to the RNA.  Cu-GGHGWRWYCR and GGHGWRWYCR were able to cleave the Fl-16SrRNA 
under all conditions, including under hydrolytic conditions with and without copper bound to it.  
MALDI-TOF MS analysis shows that these two catalysts promote cleavage of the RNA in order 
to form a 2’, 3’-cyclic phosphate at the 5th position along the RNA.  Cleavage by these two 
catalysts is interesting because it shows another possible mechanism by which the peptide 
WRWYCR may show antimicrobial activity.  With antibiotic-resistant bacteria becoming more 
prevalent, new treatments need to be developed that are able to overcome the mechanisms 
bacteria have developed.  Peptide WRWYCR is unique because it displays characteristics of 
several mechanisms of antimicrobial activity.  This makes this peptide ideal for study because it 
could possibly be used to effectively treat several different kinds of bacteria, even those that have 
developed multiple defense mechanisms. 
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